Barclays Downgrades Qiagen NV (QGEN) to Equalweight
Barclays downgraded Qiagen NV (NASDAQ: QGEN) from Overweight to Equalweight with a price target of $19.00 (from $21.00).
For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.
Shares of Qiagen NV closed at $19.88 yesterday, with a 52 week range of $15.66-$22.20.
For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.
Shares of Qiagen NV closed at $19.88 yesterday, with a 52 week range of $15.66-$22.20.